Abstract library

4 results for "Brazil".
#1548 Clinicopathological Features and Prognosis of Neuroendocrine Tumors: Analysis from a Single-Institution in Brazil
Introduction: In Brazil, information on neuroendocrine tumors (NET) is scarce. We summarized data in our center to increase knowledge of this disease in Brazilian population.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: Daniela Lacerda Costa
#2036 Extra-Pulmonary Colonic Tuberculosis Presenting as Intestinal Obstruction in a Patient with Disseminated Carcinoid Tumour
Introduction: Extra-pulmonary tuberculosis is responsible for 13% of all tuberculosis cases in Brazil. The incidence of extra-pulmonary tuberculosis is mainly linked to HIV epidemic but recent meta-analysis also correlated it with other diseases like diabetes and mental disorders.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Case reports
Presenting Author: MD Eloa Brabo
#2895 Survival Related to Treatment of Patients with Metastatic Neuroendocrine Lung Tumors Treated in a Brazilian Center
Introduction: Well-differentiated Neuroendocrine Pulmonary Tumors (NETp) are morphologically classified as Typical (TC) and Atypical Carcinoid (AC).
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Non digestive NETs (bronchial, thymic, others) - diagnosis and therapy
Presenting Author: Hugo Tanaka
#23 Developing a customized database for NET in a developing country
Introduction: The establishment of a neuroendocrine registry is extremely hard in developing countries. Many patients miss follow-up after surgical procedures and many die in different hospitals with a distinct national security health system number. As in any developing country, Brazil has a large movement of people to urban areas, making the tracking of former addresses impossible for patients who were treated some years prior. Therefore, it is more feasible to evaluate a demographic distribution of neuroendocrine tumors by topography or histological subtype, but the analysis of clinical events, such as progression-free survival, disease-free survival, time to progression or overall survival, is compromised.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: PhD Bernardo Garicochea